Tesamorelin has the strongest evidence for reducing visceral abdominal fat in adults with HIV-associated lipodystrophy, while GLP-1/GIP medications such as semaglutide and tirzepatide are generally stronger options for overall weight loss
Despite the warning label, individuals continue to use them and the individual does not know what they are getting all the time. There is some research on the following peptide injections: Body Protection Compound-157 (BPC-157) Initial and pre-clinical-trial research suggest BPC-157 may promote musculoskeletal healing, which could explain its popularity among athletes (although it is banned in professional sports)
Staroverov, V
(6) After incorporating (4) into (5)
While we focus on radiance and tone, not dramatic skin whitening claims, the improvements in skin health are undeniable
April 9, 2026 BPC-157 gut research review covering intestinal mucosal repair, tight junction protein expression, inflammatory bowel disease models, gastric mucosal research, and the gut-brain axis
